STRATEGIC SUPPORT ACROSS THE DRUG DEVELOPMENT PATHWAY

Selecting the right biomarkers to support clinical decision-making, patient stratification and proof-of-mechanism.

• Biomarker plans
• Companion diagnostics strategy
• PD and PK (living cures) endpoints
• Flow cytometry and protein biomarkers
• Biomarker data interpretation

Connecting biological insights with clinical development objectives.

• Translational strategy
• Clinical study support
• Mechanistic data interpretation
• Assay selection
• Transforming complex datasets into actionable clinical insights

Helping teams design smarter early-phase studies and reduce development risk.

• Protocol development
• Translational objectives
• Biomarker integration
• Vendor oversight

Ensuring external partners deliver high-quality scientific and operational support.

• CRO selection
• RFP preparation
• Laboratory management
• Vendor governance

Building robust processes that support compliance and data integrity.

• SOP development
• GCP/GLP alignment
• Quality oversight
• Documentation review